NELLCOR 50% GROWTH IN OEM OXIMETRY MODULE SALES IN FISCAL 1994
This article was originally published in The Gray Sheet
Executive SummaryNELLCOR 50% GROWTH IN OEM OXIMETRY MODULE SALES IN FISCAL 1994 helps inflate revenues 7.7%, to $235 mil. for the year. Nellcor reached OEM agreements with Datascope and Instrumentarium's Datex Division in its fourth quarter (ended July 3), "bringing the number of OEM and licensing partners to more than 30 medical systems and monitor manufacturers worldwide." Fourth quarter sales grew 9.6% to $65 mil.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.